VIVO
Meridian Bioscience Inc
VIVO
VIVO
Delisted
VIVO was delisted on the 30th of January, 2023.
180 hedge funds and large institutions have $836M invested in Meridian Bioscience Inc in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 50 increasing their positions, 67 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 28
25% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 67
Holders
180
Holding in Top 10
4
Calls
$5.01M
Puts
$3.15M
Top Buyers
| 1 | +$16.7M | |
| 2 | +$14.3M | |
| 3 | +$6.44M | |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$5.24M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.51M |
Top Sellers
| 1 | -$19.1M | |
| 2 | -$4.92M | |
| 3 | -$4.91M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$3.76M |
| 5 |
EARNEST Partners
Atlanta,
Georgia
|
-$3.66M |